Jin Li, MD, from Shanghai GaoBo Tumor Hospital (Affiliated to China Pharmaceutical University) and Ken Kato, MD, from the National Cancer Center Hospital, Japan, engaged in a collaborative discussion:
Breakthroughs in perioperative immunotherapy for esophageal cancer have been achieved, with multidisciplinary collaboration and international cooperation jointly driving advancements in treatment.